DK2000026T3 - Aseptiske anopheles-insekter, derudfra opnåede aseptiske plasmodium-sporozoitter og en vaccine, som omfatter aseptiske plasmodium-sporozoitter - Google Patents
Aseptiske anopheles-insekter, derudfra opnåede aseptiske plasmodium-sporozoitter og en vaccine, som omfatter aseptiske plasmodium-sporozoitter Download PDFInfo
- Publication number
- DK2000026T3 DK2000026T3 DK08013181.6T DK08013181T DK2000026T3 DK 2000026 T3 DK2000026 T3 DK 2000026T3 DK 08013181 T DK08013181 T DK 08013181T DK 2000026 T3 DK2000026 T3 DK 2000026T3
- Authority
- DK
- Denmark
- Prior art keywords
- plasmodium
- mosquitoes
- blood
- vaccine
- parasite
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 66
- 241000224016 Plasmodium Species 0.000 title claims abstract description 40
- 241000256186 Anopheles <genus> Species 0.000 title claims abstract description 36
- 244000045947 parasite Species 0.000 claims abstract description 94
- 210000003046 sporozoite Anatomy 0.000 claims abstract description 73
- 230000002238 attenuated effect Effects 0.000 claims abstract description 18
- 238000011109 contamination Methods 0.000 claims abstract description 14
- 241000255925 Diptera Species 0.000 claims description 83
- 239000005996 Blood meal Substances 0.000 claims description 37
- 235000013601 eggs Nutrition 0.000 claims description 30
- 208000015181 infectious disease Diseases 0.000 claims description 30
- 230000002458 infectious effect Effects 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 241000282414 Homo sapiens Species 0.000 claims description 17
- 241000223960 Plasmodium falciparum Species 0.000 claims description 14
- 210000000973 gametocyte Anatomy 0.000 claims description 6
- 235000016709 nutrition Nutrition 0.000 claims description 5
- 230000035764 nutrition Effects 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000008223 sterile water Substances 0.000 claims description 4
- 241000223810 Plasmodium vivax Species 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 241000223821 Plasmodium malariae Species 0.000 claims description 2
- 241001505293 Plasmodium ovale Species 0.000 claims description 2
- 230000029052 metamorphosis Effects 0.000 claims description 2
- 206010035501 Plasmodium malariae infection Diseases 0.000 claims 1
- 206010035502 Plasmodium ovale infection Diseases 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 abstract description 86
- 238000004519 manufacturing process Methods 0.000 abstract description 68
- 238000000034 method Methods 0.000 abstract description 34
- 239000003124 biologic agent Substances 0.000 abstract description 5
- 238000007710 freezing Methods 0.000 abstract description 5
- 230000008014 freezing Effects 0.000 abstract description 5
- 238000002347 injection Methods 0.000 abstract description 5
- 239000007924 injection Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 description 68
- 239000008280 blood Substances 0.000 description 68
- 230000000384 rearing effect Effects 0.000 description 34
- 235000000346 sugar Nutrition 0.000 description 31
- 241001465754 Metazoa Species 0.000 description 17
- 238000011161 development Methods 0.000 description 17
- 230000018109 developmental process Effects 0.000 description 17
- 201000004792 malaria Diseases 0.000 description 15
- 229920001971 elastomer Polymers 0.000 description 11
- 208000006877 Insect Bites and Stings Diseases 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 241000282412 Homo Species 0.000 description 8
- 230000003053 immunization Effects 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 238000005138 cryopreservation Methods 0.000 description 7
- 239000004816 latex Substances 0.000 description 7
- 229920000126 latex Polymers 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229940031567 attenuated vaccine Drugs 0.000 description 5
- 230000000774 hypoallergenic effect Effects 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000009610 hypersensitivity Effects 0.000 description 4
- 208000021267 infertility disease Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 206010003399 Arthropod bite Diseases 0.000 description 3
- 241001044169 Parum Species 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000017448 oviposition Effects 0.000 description 3
- 230000003071 parasitic effect Effects 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000003079 salivary gland Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009640 blood culture Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 229940124735 malaria vaccine Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- 241000256111 Aedes <genus> Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000256054 Culex <genus> Species 0.000 description 1
- 241000406799 Deto Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 206010064091 Iatrogenic infection Diseases 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- 241000353097 Molva molva Species 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 241001474791 Proboscis Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003430 antimalarial agent Substances 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- KUCQYCKVKVOKAY-CTYIDZIISA-N atovaquone Chemical compound C1([C@H]2CC[C@@H](CC2)C2=C(C(C3=CC=CC=C3C2=O)=O)O)=CC=C(Cl)C=C1 KUCQYCKVKVOKAY-CTYIDZIISA-N 0.000 description 1
- 229960003159 atovaquone Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008144 egg development Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229940099990 ogen Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940118768 plasmodium malariae Drugs 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- RONWGALEIBILOG-VMJVVOMYSA-N quinine sulfate Chemical compound [H+].[H+].[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 RONWGALEIBILOG-VMJVVOMYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000601 reactogenic effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000009394 selective breeding Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000005951 type IV hypersensitivity Effects 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (5)
- ASEPTISKE ΑΛ/OPHELES-I NSEKTER, DERUDFRA OPNÅEDE ASEPTISKE PLASMODIUM-SPOROZOITTER OG EN VACCINE, SOM OMFATTER ASEPTISKE PLASMODIUM-SPOROZO\TTER1. Anopheles-myg, som er fri for kontaminering med mikroorganismer, og som avles i et sterilt miljø, hvor myggene avles ud fra overfladesteriliserede æg og forsynes med filtreret luft, sterilt vand og steril udviklingsstadietilpasset ernæring under metamorfosen fra æg til voksen, hvor myggene efter at have opnået modenhed inficeres med Plasmodium-parasitter, hvor infektionen opstår som følge af, at myggene fodres med et sterilt infektiøst gametocytblodmåltid fra en blodmåltidsfodringsstation; hvor parasitterne er valgt fra gruppen bestående af P. falciparum, P. vivax, P. ovale og P. malariae, og hvor Plasmodium-sporozo\tter kan opnås fra myggene, og hvor Plasmodium-sporozoitterne er egnede til fremstilling afen vaccine til human anvendelse.
- 2. Plasmodium-sporozo\tter, som er fri for kontaminering med mikroorganismer, og som kan opnås eller er opnået fra myggene ifølge krav 1.
- 3. Plasmodium-sporozoitter ifølge krav 2, hvor Plasmodium-arten er P. falciparum.
- 4. Human vaccine, som er fremstillet ved anvendelse af Plasmodium-sporozoitterne ifølge krav 2.
- 5. Human vaccine ifølge krav 4, som er en svækket Plasmodium-sporozoitvaccine.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37058102P | 2002-04-05 | 2002-04-05 | |
| EP03718272A EP1492402B1 (en) | 2002-04-05 | 2003-04-07 | Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2000026T3 true DK2000026T3 (da) | 2015-01-05 |
Family
ID=29250550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08013181.6T DK2000026T3 (da) | 2002-04-05 | 2003-04-07 | Aseptiske anopheles-insekter, derudfra opnåede aseptiske plasmodium-sporozoitter og en vaccine, som omfatter aseptiske plasmodium-sporozoitter |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7229627B2 (da) |
| EP (2) | EP2000026B1 (da) |
| JP (3) | JP2005522214A (da) |
| AT (1) | ATE405153T1 (da) |
| AU (1) | AU2003221694A1 (da) |
| CA (1) | CA2483820C (da) |
| DE (1) | DE60323071D1 (da) |
| DK (1) | DK2000026T3 (da) |
| ES (1) | ES2526347T3 (da) |
| IL (2) | IL164384A0 (da) |
| SI (2) | SI2000026T1 (da) |
| WO (1) | WO2003087322A2 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8802919B2 (en) * | 2002-04-05 | 2014-08-12 | Sanaria Inc. | Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production |
| US8153116B2 (en) | 2006-07-11 | 2012-04-10 | University Of Connecticut | Use of conditional plasmodium strains lacking an essential gene in malaria vaccination |
| WO2008094183A2 (en) * | 2006-07-11 | 2008-08-07 | University Of Connecticut | Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination |
| DE102007034119A1 (de) * | 2007-07-21 | 2009-01-22 | Agiltera Gmbh & Co. Kg | Verwendung von Blut, Blutplasma oder Blutserum, sowie Vorrichtung und Verfahren zur Aufzucht von Fliegen-Larven |
| AU2010204887B2 (en) | 2009-01-16 | 2014-09-25 | Sanaria Inc. | Purified plasmodium and vaccine compositions |
| US20120288525A1 (en) | 2011-05-11 | 2012-11-15 | Chakravarty Sumana | Pharmaceutical compositions comprising attenuated plasmodium sporozoites and glycolipid adjuvants |
| CN102812927B (zh) * | 2012-06-21 | 2014-07-16 | 新疆维吾尔自治区疾病预防控制中心 | 自动昆虫饲血器的使用方法 |
| WO2014116990A1 (en) | 2013-01-25 | 2014-07-31 | Sanaria Inc. | Genetic attenuation of plasmodium by b9 gene disruption |
| EP3137106B1 (en) | 2014-05-02 | 2023-07-05 | Sanaria Inc. | Infectious plasmodium sporozoites grown in vitro |
| US11142317B2 (en) | 2014-09-22 | 2021-10-12 | Senecio Ltd. | Method and apparatus for artificial distribution of insects or spray |
| AU2015356564A1 (en) * | 2014-12-04 | 2017-07-13 | Senecio Ltd. | Release method for insect distribution |
| US10159228B2 (en) | 2016-07-06 | 2018-12-25 | Aspire Food Group USA Inc. | Precision water delivery system for insects |
| US10561127B2 (en) | 2016-09-09 | 2020-02-18 | Verily Life Sciences Llc | Blood feeding system using nonwoven fabric materials |
| SG11201906740YA (en) | 2017-01-22 | 2019-08-27 | Senecio Ltd | Automatic handling and sorting of insects for growth and release |
| US11051490B2 (en) * | 2017-03-27 | 2021-07-06 | The United States Of America, As Represented By The Secretary Of Agriculture | Insect water supply system |
| EP3648586A2 (en) | 2017-07-06 | 2020-05-13 | Senecio Ltd. | Method and apparatus for sex sorting of mosquitoes |
| KR102201230B1 (ko) * | 2017-08-09 | 2021-01-11 | 고려대학교 산학협력단 | 광릉왕모기 대량 사육 시스템 |
| CN110754437B (zh) * | 2019-11-05 | 2021-10-15 | 北京蓝狐天敌技术有限公司 | 一种异色瓢虫培养装置 |
| CN118140877B (zh) * | 2024-05-11 | 2024-07-12 | 云南千淇生物科技有限公司 | 一种叉角厉蝽养殖用饲养装置及饲养方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4850305A (en) * | 1987-12-02 | 1989-07-25 | Cornell Research Foundation, Inc. | Artificial system and method for breeding fleas |
| US5113799A (en) * | 1990-05-02 | 1992-05-19 | Crop Genetics International Corporation | Method and apparatus for mass producing insects entomopathogens and entomoparasites |
| US5133289A (en) * | 1991-09-05 | 1992-07-28 | Cornell Research Foundation, Inc. | Artificial system and method for breeding fleas |
| JP2513135B2 (ja) * | 1993-07-15 | 1996-07-03 | 日本電気株式会社 | 簡易入力装置 |
| US5983557A (en) * | 1997-11-06 | 1999-11-16 | The United States Of America As Represented By The Secretary Of The Army | Lethal mosquito breeding container |
| DE19925996A1 (de) * | 1999-06-08 | 2000-12-14 | Wilhelm Fleischmann | Verfahren und Vorrichtung zur Herstellung des Sekrets von Fliegenlarven für die therapeutische Applikation |
-
2003
- 2003-04-07 EP EP08013181.6A patent/EP2000026B1/en not_active Expired - Lifetime
- 2003-04-07 ES ES08013181.6T patent/ES2526347T3/es not_active Expired - Lifetime
- 2003-04-07 CA CA2483820A patent/CA2483820C/en not_active Expired - Fee Related
- 2003-04-07 DE DE60323071T patent/DE60323071D1/de not_active Expired - Fee Related
- 2003-04-07 AU AU2003221694A patent/AU2003221694A1/en not_active Abandoned
- 2003-04-07 SI SI200332402T patent/SI2000026T1/sl unknown
- 2003-04-07 AT AT03718272T patent/ATE405153T1/de not_active IP Right Cessation
- 2003-04-07 DK DK08013181.6T patent/DK2000026T3/da active
- 2003-04-07 EP EP03718272A patent/EP1492402B1/en not_active Expired - Lifetime
- 2003-04-07 WO PCT/US2003/010797 patent/WO2003087322A2/en active Application Filing
- 2003-04-07 IL IL16438403A patent/IL164384A0/xx unknown
- 2003-04-07 JP JP2003584266A patent/JP2005522214A/ja active Pending
- 2003-04-07 SI SI200331432T patent/SI1492402T1/sl unknown
-
2004
- 2004-10-04 IL IL164384A patent/IL164384A/en not_active IP Right Cessation
- 2004-10-04 US US10/958,163 patent/US7229627B2/en not_active Expired - Lifetime
-
2007
- 2007-07-19 JP JP2007188660A patent/JP2008022851A/ja active Pending
-
2010
- 2010-06-10 JP JP2010133370A patent/JP2010187705A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SI2000026T1 (sl) | 2015-02-27 |
| IL164384A (en) | 2014-04-30 |
| ES2526347T3 (es) | 2015-01-09 |
| US7229627B2 (en) | 2007-06-12 |
| AU2003221694A1 (en) | 2003-10-27 |
| IL164384A0 (en) | 2005-12-18 |
| AU2003221694A2 (en) | 2003-10-27 |
| ATE405153T1 (de) | 2008-09-15 |
| JP2010187705A (ja) | 2010-09-02 |
| CA2483820C (en) | 2015-07-14 |
| EP2000026B1 (en) | 2014-09-24 |
| CA2483820A1 (en) | 2003-10-23 |
| WO2003087322A2 (en) | 2003-10-23 |
| EP2000026A1 (en) | 2008-12-10 |
| JP2005522214A (ja) | 2005-07-28 |
| EP1492402B1 (en) | 2008-08-20 |
| EP1492402A2 (en) | 2005-01-05 |
| JP2008022851A (ja) | 2008-02-07 |
| EP1492402A4 (en) | 2005-06-22 |
| US20050100532A1 (en) | 2005-05-12 |
| SI1492402T1 (sl) | 2009-02-28 |
| WO2003087322A3 (en) | 2003-12-04 |
| DE60323071D1 (de) | 2008-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2000026T3 (da) | Aseptiske anopheles-insekter, derudfra opnåede aseptiske plasmodium-sporozoitter og en vaccine, som omfatter aseptiske plasmodium-sporozoitter | |
| US8802919B2 (en) | Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production | |
| Luckey | Germfree life and gnotobiology | |
| Crampton et al. | The molecular biology of insect disease vectors: a methods manual | |
| Stoll | Axenic cultivation of the parasitic nematode, Neoaplectana glaseri, in a fluid medium containing raw liver extract | |
| Wang et al. | An efficient rearing system rapidly producing large quantities of poultry red mites, Dermanyssus gallinae (Acari: Dermanyssidae), under laboratory conditions | |
| Chin et al. | Study of insect succession and rate of decomposition on a partially burned pig carcass in an oil palm plantation in Malaysia | |
| Willmott et al. | Use of a cold-active entomopathogenic nematode Steinernema kraussei to control overwintering larvae of the black vine weevil Otiorhynchus sulcatus (Coleoptera: Curculionidae) in outdoor strawberry plants | |
| Lord et al. | Forensic entomology: the use of insects in the investigation of homicide and untimely death | |
| CN105145546A (zh) | 一种蜜蜂雄蜂精液的保存液及其制备方法 | |
| Hinkle et al. | Flea rearing in vivo and in vitro for basic and applied research | |
| Va et al. | Wonder animal model for genetic studies-Drosophila melanogaster–its life cycle and breeding methods–a review | |
| RIDING et al. | Some observations on a Tylenchid nematode Howardula sp. parasitizing the mushroom phorid Megasalia halterata (Phoridae, Diptera) | |
| Anderson et al. | Studies on Dictyocaulus filaria. I. Modifications of laboratory procedures | |
| Cooper et al. | Butterfly houses | |
| Foster | Colonization and maintenance of mosquitoes in the laboratory | |
| Ismail et al. | Accelerating Chrysomya megacephala maggot growth for forensic entomology cases | |
| CN111727936A (zh) | 一种二化螟盘绒茧蜂的室内繁殖方法 | |
| Glaser | Acquired immunity in silkworms | |
| Sandground | Observations on Rhabditis hominis Kobayashi in the United States | |
| Sari | The rearing of Microplitis manilae (Hymenoptera: Braconidae) on Spodoptera litura Fabricius (Lepidoptera: Noctuidae) feed different diets | |
| CN208402887U (zh) | 一种用于收集蜜蜂的试验箱体 | |
| Morris | Anthrax: Transmisson of Infection by Non-biting Flies | |
| Mahmood | Laboratory maintenance of mosquitoes | |
| Zhang et al. | Production of Hymenolepis diminuta in the Laboratory: An Old Research Tool with New Clinical Applications |